European Association for the Study of Diabetes
LightNews LightNews
banner
easdnews.bsky.social
European Association for the Study of Diabetes
@easdnews.bsky.social
900 followers 97 following 410 posts
We promote excellence in #diabetes #care through #research, #networking and #education.

The European Association for the Study of Diabetes e.V. (EASD) is a membership-based academic non-profit organization. It was founded in 1965, headquartered in Germany
Posts Replies Media Videos
easdnews.bsky.social
🎬 The EASD Early Career Academy 'Best of EASD 2025' ep. 5️⃣is live! Dr. Lorenzo Nesti (Società Italiana di Diabetologia) shares key insights on #exercise adaptation in #diabetes, how exercise timing affects glucose #metabolism, how activity can reduce appetite & more.

🔗👉 youtube.com/watch?v=CDTloG
December 8, 2025 at 12:32 PM
easdnews.bsky.social
🎙️"Five years ago, we wouldn't be sitting here having this conversation."

In this landmark interview, experts reflect on how decades of research have brought #T1D care to a turning point: population #screening is moving from vision to policy.

🎧👉 Listen now: www.easd.org/media-centre...
Graphic showing a panel discussion with three women (Prof. Anette Ziegler, Prof. Chantal Mathieu and Anastasia Albanese-O'Neill) seated on stage, each holding a turquoise EASD-branded microphone. The left half features the panel in a conference setting; the right half has a blue gradient background with the EASD logo. Soundwave graphics stretch across the centre. Text at the bottom reads: ‘Population level screening to detect early stage type 1 diabetes.’
December 5, 2025 at 12:48 PM
easdnews.bsky.social
🚀 Applications are open for the 2nd EASD #Diabetes #Technology #School 2026! This 3-day in-person programme is designed for HCPs who want to deepen their knowledge & skills in current & emerging diabetes technologies.

📅 Deadline: 5 Jan 2026

🔗 Learn more and apply now: www.easd.org/education/me...
Banner for the "2nd Diabetes Technology School" event, held from April 16-18, 2026, in Vienna, Austria. The banner highlights the themes "Advances in Diabetes Technology" and "Innovations and Applications" with images of diabetes technology devices such as a continuous glucose monitor, insulin pump, and a smartphone app displaying glucose data. The European Association for the Study of Diabetes (EASD) logo is displayed in the bottom left corner, along with the website easd.org.
December 4, 2025 at 12:47 PM
easdnews.bsky.social
🚨Applications are open for the #EFSD /Novo Nordisk Foundation Future Leaders Award! This 5 year programme supports rising #diabetes researchers in 🇪🇺 as they advance toward independent, tenured roles.

📅 Deadline: 2 Mar 2026 |🕛 12:00 CET

Apply now 👉 www.europeandiabetesfoundation.org/programmes/p...
Promotional graphic titled ‘Call for Applications’ for the EFSD/Novo Nordisk Foundation Future Leaders Award Programme. Text explains support for clinical and basic scientists in European diabetes research as they transition to tenured academic positions and develop as future leaders. The right side shows a scientist looking into a microscope. EFSD logo and europeandiabetesfoundation.org appear at the bottom.
December 4, 2025 at 9:59 AM
easdnews.bsky.social
🚀 Meet @metabologiajnl.bsky.social's #EditorInChief @jenniferlsargent.bsky.social in a new #ExpertInsights ep. She shares how our new journal will bridge #diabetes & #metabolism science, connecting basic, clinical & public health #research🌍

📺Watch now & submit 👉 link.springer.com/journal/4435....
December 3, 2025 at 1:35 PM
easdnews.bsky.social
⚠️ @easdnews.bsky.social expresses deep concern over Novo Nordisk’s decision to discontinue several key human #insulin products across #Europe. These long-used insulins remain essential for many & their withdrawal will have significant implications.

Read full statement 👉 www.easd.org/uploads/EASD...
Graphic titled ‘EASD Statement of Regret’ with a background image of multiple insulin vials and a syringe. Main text reads: ‘Planned Discontinuation of Key Human Insulin Products by Novo Nordisk.’ The EASD logo and the text ‘European Association for the Study of Diabetes’ appear at the bottom.
December 3, 2025 at 10:31 AM
easdnews.bsky.social
🌟 Meet Dr Francesca Cinti. Her work shows how islet innervation drives beta-cell de differentiation in #T2D, identifying a noradrenergic intrapancreatic signal as a promising therapeutic target.

📖 www.diabetesresearchclinicalpractice.com/article/S016...

Supported by @astra-zeneca.bsky.social.
A promotional graphic titled “Recipient Research Portrait...” featuring a circular photo of a woman in a white lab coat smiling in a bright indoor setting. Text reads: “Doctor Francesca Cinti, Catholic University of the Sacred Heart, Rome.” At the bottom is the EFSD (European Foundation for the Study of Diabetes) logo. A graphic with the heading “The role of islet innervation in human type 2 diabetes.” Below, text explains that Francesca Cinti’s research focuses on how neural signalling promotes beta-cell dedifferentiation and impairs beta-cell function, aiming to identify new therapeutic targets for diabetes. EFSD logo appears at the bottom. A graphic stating that the work is supported by the EFSD Future Leaders Mentorship Programme for Clinical Diabetologists, funded by an educational grant from AstraZeneca. Large text below reads: “Apply for research grants and fellowships - europeandiabetesfoundation.org.” Decorative curved shapes appear in the background.
December 2, 2025 at 2:34 PM
easdnews.bsky.social
📺 Discovering what drives hypoglycaemia from level 1 ➡️ level 2 is key for improving patient care. This week in the EASD Early Career Academy's Best of EASD 2025 series, Dr. Vaios Koutroukas ( @abcdiab.bsky.social ) shares insights from the HYPOmetric study.

👉 www.youtube.com/watch?v=aNUr...
Graphic titled ‘Best of EASD 2025 by the EASD Early Career Academy’ on a red background with a white Ferris wheel illustration on the left. A circular photo shows a smiling man with glasses and a beard. Text reads: ‘Featuring… Vaios Koutroukas, UK’ and ‘Highlighting… Exploring factors promoting progression from level 1 to level 2 hypoglycaemia in the HYPO-METRICS study.’ The EASD 2025 Vienna logo appears in the bottom right corner.
December 1, 2025 at 2:07 PM
easdnews.bsky.social
🚀 Exciting news! @metabologiajnl.bsky.social , our newest open-access journal & sister journal to @diabetologiajnl.bsky.social , is accepting submissions.

Publishing research on diabetes, #obesity, metabolic disorders, & more.

📝 Learn more & submit: metabologia.org

#DiabetesResearch #OpenAccess
A circular, layered graphic on a blue gradient background featuring fluorescent microscopic imagery of colourful cells (green, pink, and blue) inside the central circle. Overlaid text reads ‘Metabologia - Journal of the European Association for the Study of Diabetes (EASD).’ The design includes overlapping curved bands in white, light blue, and teal surrounding the central image.
November 28, 2025 at 1:35 PM
easdnews.bsky.social
🎙️ Last week, we heard the diabetologist's view. This week, we hear the cardiologist's take: Dr. Matthew Cavender (University of North Carolina) further breaks down the results of the SOUL trial & why #Collaboration is key to transforming patient care.

🎧 Listen now: www.easd.org/media-centre...
A promotional graphic from EASD (European Association for the Study of Diabetes). On the left side, there is a man (Prof. Matthew Cavender - University of North Carolina) in a suit speaking into a blue microphone labeled “EASD LIVE”. The design includes curved blue shapes and an audio-wave graphic in the center, suggesting this is related to a podcast or interview. At the bottom, the text reads: “Results from the SOUL Trial: The cardiologists' perspective.”
November 28, 2025 at 10:38 AM
easdnews.bsky.social
The EASD Robert Turner Course is open for #applications. The 4-day programme offers junior doctors training in clinical #research design, stats & "R" programming.

📅 16 - 20 Mar 2026 |📍@kebleoxford.bsky.social

Apply by 5 Jan 2026👉 www.easd.org/education

Supported by Lilly Diabetes International.
Promotional banner for the EASD Robert Turner Clinical Research Training Course, taking place 16-20 March 2026 in Oxford, UK. A red corner label reads ‘Apply Now!’. The design includes photos of Oxford landmarks, including the Radcliffe Camera and surrounding historic university buildings. The EASD logo and the text ‘European Association for the Study of Diabetes’ appear at the bottom, along with the website easd.org.
November 27, 2025 at 1:45 PM
easdnews.bsky.social
🔬 Applications are open for the #EFSD & #NovoNordisk A/S Programme for #DiabetesResearch in 🇪🇺. Open to researchers at non-profit institutions working on innovative #diabetes projects.

📅 Deadline: 2 Feb 2026

Apply now 👉 www.europeandiabetesfoundation.org/programmes/p...

Supported by Novo Nordisk.
Banner announcing ‘Call for Applications’ for the EFSD and Novo Nordisk A/S Programme for Diabetes Research in Europe. Text states support for all fields of diabetes research, including basic and clinical research. The design features overlapping shapes in blue, green, and teal, with an image of a laboratory pipette above test tubes on the right. EFSD logo and the website europeandiabetesfoundation.org appear at the bottom.
November 27, 2025 at 10:17 AM
easdnews.bsky.social
👉 New research shows that #T1D doubles the risk of #dementia, w. vascular dementia standing out.
“Our study provides the clearest evidence to date,”says PI Thomas van Sloten(@umcutrecht.bsky.social)&co-author @profnaveedsattar.bsky.social (@uofglasgow.bsky.social):
easd-elearning.eu/news/459/Dem...
Infographic summarising a nationwide Swedish cohort study on dementia risk in people with type 1 diabetes (T1D). The study includes 43,400 individuals with T1D and 217,109 matched controls. Results table: T1D vs controls - all-cause dementia HR 2.02 (95% CI: 1.83-2.23), Alzheimer’s disease HR 1.38 (1.13-1.69), vascular dementia HR 3.73 (3.07-4.52), and non-Alzheimer-nonvascular dementia HR 1.87 (1.63-2.15). Risk factors for all-cause dementia in T1D: age per 1 year HR 1.14; single status HR 1.56; HbA1c per 10 mmol/mol HR 1.10; higher education HR 0.66 (protective); systolic BP per 10 mmHg HR 1.07; history of stroke/TIA HR 2.65. Reference line at HR 1.00. Includes abbreviations HR, CI, SBP, T1D.
November 26, 2025 at 1:43 PM
easdnews.bsky.social
⏳ Last chance to apply for the 2nd EASD Early Career Academy Meeting offering 3-days dedicated to strengthening research skills, collaboration & supporting #earlycareer professionals in #diabetes.

📅 30 Mar - 1 Apr 2026 |📍Düsseldorf 🇩🇪
⏳ Deadline: 2 Dec 2025

Apply now 👉 www.easd.org/academy/acad...
easdnews.bsky.social European Association for the Study of Diabetes @easdnews.bsky.social · 28d
We’re thrilled to confirm the 2nd Early Career Academy Meeting:

📅 30 March - 1 April 2026 |📍 Düsseldorf, Germany

This meeting will bring together early career researchers to connect & collaborate on advancing #diabetes #research & #care.

📝 Apply by 2 December 2025

🔗👉 www.easd.org/academy/acad...
November 26, 2025 at 11:44 AM
easdnews.bsky.social
Meet Dr. Oana Patricia Zaharia, recipient of the EASD Rising Star Symposium & #EFSD Rising Star Fellowship Programme.

📖 Read full publication: diabetesjournals.org/care/article...

💡Applications are now open: www.europeandiabetesfoundation.org/programmes/p...

Supported by @novonordisk.bsky.social
A graphic titled “Recipient Research Portrait…” featuring a portrait photo of Dr. Oana Patricia Zaharia, who is smiling and wearing glasses and a patterned shirt. The text identifies her as a Doctor from the German Diabetes Center. EFSD’s logo and full name, “European Foundation for the Study of Diabetes,” appear at the bottom. A graphic titled “Refining novel diabetes classifications by using markers of adipogenesis and adipose tissue distribution.” Below, a text box explains that Oana Patricia Zaharia investigates whether lipids in skeletal muscle or adipose tissue volumes are elevated in the severe insulin-resistant diabetes (SIRD) endotype and contribute to complications. The EFSD logo appears at the bottom. A graphic stating that the work is supported by the “EFSD Rising Star Research Fellowship supported by Novo Nordisk.” The bottom section reads “Apply for research grants and fellowships” with the EFSD website “europeandiabetesfoundation.org.” The background contains EFSD brand colors and abstract circular shapes.
November 25, 2025 at 2:07 PM
easdnews.bsky.social
🎧 Hear Dr Sindre Lee-Ødegård break down his top highlights from #EASD2025 in the latest "Best of EASD 2025" ep. From #PrecisionMedicine in monogenic #diabetes to tissue-specific insulin resistance, new #GLP-1 data & the impact of #diabetes distress.

👉 Watch now: www.youtube.com/watch?v=JVg9...
A red graphic titled “Best of EASD 2025 by the EASD Early Career Academy.” On the left, a white outline of a Ferris wheel extends across the background. Below it, there is a circular photo of a man with short dark hair, wearing a dark jacket, standing outdoors with blurred trees behind him. To the right of the photo, blue text reads “featuring… Sindre Lee-Ødegård, Norway” and “highlighting… From insulin resistance to heart health.” In the lower right corner is the EASD 2025 Vienna logo.
November 24, 2025 at 2:37 PM
easdnews.bsky.social
⏰Last call - applications closing soon!
Apply now for EASD’s 1st Immunology School for Endocrinology to explore
✅ Latest #immunology concepts in #T1D,
✅ Early detection and disease staging,
✅ Disease-modifying therapies and #betacell replacement
👉 www.easd.org/education/me...
easdnews.bsky.social European Association for the Study of Diabetes @easdnews.bsky.social · Oct 9
📢 EASD will host its 1st Immunology School for Endocrinology: #Immunology in #Type1Diabetes - bridging the science and clinical impact.

📅 26 - 27 March 2026 |📍Vienna, Austria

Open to EASD Members; doctors, researchers/pharmacists in endocrinology/diabetology.

Apply 👉 www.easd.org/education/me...
Promotional graphic for the “1st Immunology School for Endocrinology,” taking place on 26-27 March 2026 in Vienna, Austria. The design features a blue gradient background with white and turquoise text. On the right side, there are images of a gloved hand performing a finger-prick blood test and stylized blue virus-like illustrations. At the bottom, the EASD (European Association for the Study of Diabetes) logo and the website “easd.org” are displayed.
November 24, 2025 at 10:30 AM
easdnews.bsky.social
👇🎥 In case you missed it! On #WorldDiabetesDay2025, the EASD Early Career Academy hosted a webinar on “The role of the #placenta in diabetes” with Prof. Gernot Desoye.

The full recording is now available. Watch now 👉 www.youtube.com/watch?v=i8RI...

#diabetes #webinar #pregnancy
November 21, 2025 at 2:00 PM
easdnews.bsky.social
🎙️Can an oral GLP-1 RA match injectable outcomes?

This week, we hear the diabetologist’s take on the #SOULtrial. Dr Rodica Busui explains the 14% MACE reduction with an oral agent, plus insights on HFpEF, SGLT2i combos & what it means for real-world care.

🎥👉 www.easd.org/media-centre...
November 21, 2025 at 10:01 AM
easdnews.bsky.social
🏆 We’re pleased to announce the 2025 recipients of the #EFSD /Sanofi European #Diabetes Research Programme on Autoimmunity in #T1D. This Programme supports basic & clinical research across 🇪🇺 .

Learn more 👉 www.europeandiabetesfoundation.org/recipients/e...

Supported by @sanofifr.bsky.social.
The image displays a banner for the EFSD and Sanofi European Diabetes Research Programme on Autoimmunity in Type 1 Diabetes (T1D). It highlights the 2025 grant recipients: Paul McKeigue from the University of Edinburgh, United Kingdom. Paolo Monti from San Raffaelle Vita-Salute University, Italy. Joachim Størling from Steno Diabetes Center Copenhagen, Denmark. The image also includes the logos for EFSD and a link to the European Diabetes Foundation website (europeandiabetesfoundation.org). The background is divided into different color blocks (blue, green, and light blue).
November 20, 2025 at 1:15 PM
easdnews.bsky.social
🌏EASD in China 2025 brought Vienna insights to Tianjin 🇨🇳!Leading experts shared advances in #CKM syndrome, #GLP1 & SGLT2 therapies & emerging tech in #diabetes care. A meeting for global #collaboration & translating evidence into practice.

Read report🔗 www.easd.org/education/sy...

#DiabetesCare
Promotional graphic for the 'EASD in China 2025 Meeting' featuring the text: 'Fostering exchange, enhancing collaboration, and advancing diabetes research and care across Chinese and European communities.' The design includes three circular photos of speakers at a podium, with abstract curved blue lines in the background. The EASD logo and website (easd.org) are displayed at the bottom.
November 20, 2025 at 10:44 AM
easdnews.bsky.social
📣 Final weeks to apply for the 2nd Early Career Academy Meeting! A 3-day programme for early-career researchers to learn, collaborate and connect with #diabetes experts.

📅 30 March - 1 April 2026 |📍Düsseldorf
⏰ Deadline: 2 December 2025

Explore the programme and apply now 👉 easd.org/academy/academ
Banner for the 2nd EASD Early Career Academy Meeting with the tagline ‘Shaping the Future of Diabetes Research and Care.’ The event dates are 30 March–1 April 2026 in Düsseldorf, Germany. On the right side is a photo of the Deutsches Diabetes-Zentrum (DDZ) building with blue and white geometric patterns, accompanied by the DDZ logo.
November 19, 2025 at 1:05 PM
easdnews.bsky.social
🚶‍♀️Can #GLP1RA help people living with #T2D and #PAD walk farther without pain?

Assoc. Prof. Alice Cheng discusses the #STRIDE trial results & why PAD deserves more attention in #diabetescare in our latest EASD e-Learning #ExpertInsights episode.

📺🔗 Watch now: easd-elearning.eu/episode/354/...
November 19, 2025 at 10:34 AM
easdnews.bsky.social
🧠Meet Dr. Jurga Laurencikiene (@ki.se) recipient of the #EFSD / @novonordisk.bsky.social A/S Programme for Diabetes Research in 🇪🇺 grant to explore the dual role of adipose tissue inflammation.

📚Publications:
1️⃣ pubmed.ncbi.nlm.nih.gov/39261467/
2️⃣ pubmed.ncbi.nlm.nih.gov/38460092/

#diabetesresearch
Recipient Research Portrait featuring Doctor Jurga Laurencikiene from Karolinska Institute, Huddinge. The design uses turquoise, lime green, and white curved elements. A circular photo shows a woman with wavy blonde hair wearing a dark blue patterned top, smiling at the camera in an office setting. The EFSD (European Foundation for the Study of Diabetes) logo appears at bottom left with their full name. Research project description slide with curved design elements in green, blue, and turquoise. Title reads 'Type 2 diabetes and adipose tissue morphology: dual role and sex-specificity of the immune component' in dark blue text on a mint green banner. Below, on a lime green background, text explains: 'Jurga Laurencikiene examines the crosstalk and interaction between inflammation and metabolism in human adipose tissue, providing insights into their regulation by sex hormones.' EFSD logo and name appear at bottom. Promotional graphic for the EFSD/Novo Nordisk A/S Programme for Diabetes Research in Europe. The design features curved blue and turquoise diagonal stripes on a light blue background. Text reads 'Supported by the' in a green banner at top, followed by the programme name in a teal box, and 'Apply for research grants and fellowships' in white text on a dark blue banner. Website europeandiabetesfoundation.org appears at bottom.
November 18, 2025 at 3:00 PM
easdnews.bsky.social
Hear different impressions from the EASD Academy's latest "Best of EASD 2025" videos, where #earlycareer #researchers share their highlights from the EASD 2025 Annual Meeting.

This week, Dr Eugenia Martín Vázquez discusses what's new in #T1D research.

Watch the full episode 👉 youtu.be/udpCzkq8l-s
November 17, 2025 at 12:34 PM